Run-in-a-Million Run from San Francisco to Los Angeles to Raise Awareness About AIDS and H... (/p Day 5 Monterey to Big Sur Da...)

(Date:1/7/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...hey received $7.5 million pursuant to the joint ve...nc. to commercialize and develop Zevalin(R) in the...the initial $7.5 million payment in connection wit...y earn up to an additional $15 million in product ...

(Date:1/7/2009)...toward containing health care costs could have the...uctivity, impairing quality and perhaps even incre...ter physicians suggest in a New England Journal o...havioral economics and psychology, Pamela Hartzban...t assigning a monetary value to every aspect of a ...

(Date:1/7/2009)...Jan, 7 Natural Alternatives International, Inc. (...nufacturer and marketer of customized nutritional ...er 31, 2008 its former President, Randell Weaver,s...d it completed certain amendments to its credit fa... the amendments extend the maturity date for the w...

(Date:1/7/2009)...n. 7 WellPoint, Inc. (NYSE: WLP ) announced,tod...at the 27th Annual J.P.,Morgan Healthcare Conferen...,Time (12:30 p.m. Eastern Standard Time). , We...ults for the three,months ended Dec. 31, 2008, on ...a quiet period prior to this scheduled earnings re...

Breaking Medicine News(10 mins):Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 2 Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 3 Health News:Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals 4 Health News:Cost containment focus could have consequences for health care delivery 2 Health News:Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension 2 Health News:WellPoint Announces Appearance at Upcoming Conference 2

[0] Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals [0] Cost containment focus could have consequences for health care delivery [0] Natural Alternatives International, Inc. Announces Change in Executive Officer and Loan Modification and Extension [0] WellPoint Announces Appearance at Upcoming Conference

...w survey by Cancer Research UK says that obese peo...cancer and think they must slim down// only to loo...found that 40% thought looking good was the main r...ile 32% were aware that it lessened cancer risk. "...

... Ridge: The United States Department of Agricultur...he Special Supplemental Nutrition Program// for Wo.... The USDA's proposal will look at reducing the qu...of the food packages. The proposal has indicated t...

...ean-Congo Haemorrhagic Fever (CCHF) has killed at ... of it ever reported since it was identified// in ...s more cases of the Ebola-like disease are bound ... of this disease were reported. .Six provinces in ...

...w screening system combining digital photography w...tive method to screen for a common childhood oral ...er city toddlers. Early childhood dental caries...ottle tooth decay, results from prolonged exposure...

Other Medicine News:Health News:Proposal to revamp WIC food package 2 Health News:Crimean-Congo Hemorrhagic Fever hits Turkey 2 Health News:New Screening System For Early Detection Of Dental Caries in Toddlers 2 Health News:New Screening System For Early Detection Of Dental Caries in Toddlers 3

Many People Ignorant Over Obesity's Cancer Link Proposal to revamp WIC food package Crimean-Congo Hemorrhagic Fever hits Turkey New Screening System For Early Detection Of Dental Caries in Toddlers

(Date:1/6/2009)...RNewswire/ -- Pacira Pharmaceuticals, Inc., an,ac...ed today that enrollment,has been completed in tw...,safety and efficacy of a single intraoperative ad... prolonged postoperative analgesia. , Resul...al knee,arthroplasty (TKA) are expected to provid...

(Date:1/3/2009)...EMONT, Ill., Jan. 2 Mag...ogy providing an increasing number of clinical ben...ording to an article in the January 2009 issue of ... Surgeons ( http://www.jaaos.org/ ). It is predic...echnical developments will allow MRI to provide ev...

(Date:12/27/2008)...ar silence, offers to ease cloning costs for Clona...Dec. 27 Six years to th...d child, Dr. Brigitte Boisselier, head of the comp...ther babies cloned by her company are growing up h... families, privacy. , , "We,ve helped almost 10...

(Date:12/17/2008)...FirstCall/ -- Medivation, Inc.,(Nasdaq: MDVN ) ...llment in a,Phase 1-2 dose-escalation clinical tr...onist, in castration-resistant prostate cancer pat...S. Food and Drug Administration (FDA) to,advance ... open-label, U.S. Phase 1-2 study evaluated prosta...

Breaking Medicine Technology:Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2 Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3 MRI Emerges As Vital Resource in Treatment of Back Pain 2 MRI Emerges As Vital Resource in Treatment of Back Pain 3 'We're Ready to Prove It!' 2 Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 2 Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 3 Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients 4 Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday August 5 2008 24489 1 Cardica to Announce Fiscal 2008 Fourth Quarter and Year End Financial Results on Tuesday August 5 2008 24489 2 DoctorDirectory to Co market VoSpire ER 28R 29 with DAVA Pharmaceuticals Inc 24486 1 DoctorDirectory to Co market VoSpire ER 28R 29 with DAVA Pharmaceuticals Inc 24486 2 InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 1 InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 2 InfoLogix Selected by University Medical Center to Deploy Mobile Wireless Asset Tracking Solution 24483 3 Poniard Pharmaceuticals Announces Upcoming Conference Participation 6783 1 Poniard Pharmaceuticals Announces Upcoming Conference Participation 6783 2

[3] Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment [3] MRI Emerges As Vital Resource in Treatment of Back Pain [1] 'We're Ready to Prove It!'[2] Medivation Completes Enrollment of Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients

...., May 09, 2007 /PRNewswire-FirstCall/ --,Catalyst...itive,initial, top-line results from a bioequivale...igabatrin Tablets) is bioavailable and,bioequivale...rketed,in Europe by Sanofi Aventis. These data pot...e extensive body of published pre-clinical,and cli...

...if.--(BUSINESS WIRE)--May 10, 2007 - According to,...65 percent of,female respondents seeking treatment...Painkillers such as Vicodin, OxyContin, Percocet,a...n, 35 percent of,the mothers who reported a depend... to Clare Waismann, registered addiction,specialis...

Other Medicine Technology:Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 2 Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 3 Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction 4 Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers 2

Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results,of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Company's,Investigational Drug to Treat Cocaine and Methamphetamine Addiction Waismann Method Survey Reveals 65 Percent of Women Seeking Opiate,Dependency Treatment Are Mothers

Pneumatic impactor, general surgery, available in various hose connector styles.

The SmartDriver System consists of a pistol-grip handpiece available in Pneumatic, Electric and Battery Power, with a wide range of couplers that can be used in a variety of orthopedic surgical appli

Introducing the new large power line from MicroAire. Our new handpieces function as both cordless AND electric instruments, offering the ultimate in flexibility. Its the versatility the industry has

The 7600 Oscillating Saw offers unparalleled power for large bone osteotomies, thanks to its 14.4V NiMH Rechargeable Battery Pack. The cutting head may be rotated into 12 positions for cutting in any

Medicine Products:

Micro Impactor SmartDriver Powermaster Drill/Reamer Large Power Battery/Electric Oscillating Saw

Run-in-a-Million Run from San Francisco to Los Angeles to Raise Awareness About AIDS and H...(/p Day 5 Monterey to Big Sur Da...),Health